Filing Details

Accession Number:
0001144204-16-104222
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-23 16:36:35
Reporting Period:
2016-05-16
Filing Date:
2016-05-23
Accepted Time:
2016-05-23 16:36:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369868 China Biologic Products Inc. CBPO Biological Products, (No Disgnostic Substances) (2836) 752308816
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1584733 Cbpo Gang Yang 18Th Floor, Jialong International
Building, 19 Chaoyang Park Road
Beijing F4 100125
Corporate Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-16 40,000 $12.26 62,205 No 4 M Direct
Common Stock Disposition 2016-05-19 14,858 $113.83 47,347 No 4 S Direct
Common Stock Disposition 2016-05-20 11,705 $113.40 35,642 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-05-16 40,000 $0.00 40,000 $12.26
Common Stock Stock Option (right to buy) Disposition 2016-05-16 11,250 $0.00 11,250 $9.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2010-10-11 2020-07-11 No 4 M Direct
3,750 2013-09-01 2022-08-31 No 4 M Direct
Footnotes
  1. Represents 14,858 shares of common stock (the "May 19 Sold Common Stock") sold on the open market at a weighted average price of $113.83 per share on May 19, 2016, and 11,705 shares of common stock (the "May 20 Sold Common Stock," and together with the May 19 Sold Common Stock, the "Sold Stock") sold on the open market at a weighted average price of $113.40 per share on May 20, 2016. The Sold Stock was acquired by the Reporting Person through the exercise of stock options to purchase 40,000 shares of the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options. The Reporting Person intends to use the proceeds from the sales of the Sold Stock to pay income tax due in connection with the Reporting Person's exercise of the stock options disclosed in Footnotes 4 and 5 to this Form 4.
  2. The price reported in Column 4 is a weighted average price. The May 19 Sold Common Stock was sold in multiple transactions in the open market at prices ranging from $113.50 to $115.35, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3 to this Form 4.
  3. The price reported in Column 4 is a weighted average price. The May 20 Sold Common Stock was sold in multiple transactions in the open market at prices ranging from $113.00 to $114.00, inclusive.
  4. Represents previously reported stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated July 11, 2010. The options were scheduled to vest in 12 equal portions on a quarterly basis over a three-year period, with the initial vesting date being October 11, 2010, provided that the Reporting Person is employed by the Issuer on each vesting date.
  5. Represents previously reported stock options to purchase 11,250 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.